The growth in mobile device sales is helping to reshape the landscape in the hardware component market, according to analysts.
Research firm IHS said that shipments of mobile DRAM chips have continued to climb despite a trend downwards in the larger flash memory market.
The company said that in the second quarter of 2012, mobile chip revenues hit some $1.85bn, up from $1.83bn in the previous quarter. Samsung was tabbed as the top seller with a 61 percent market share, followed by Hynix and Elpida.
Analysts noted that the growth in mobile DRAM indicates a remarkable shift is underway in the DRAM space.
While mobile sales accounted for just 19 percent of the overall market revenues a year ago, IHS said that last quarter mobile took a 26 percent share of the total market.
"This sustained growth is courtesy of the continued propulsive expansion of the smartphone and tablet markets, the two main consumers of mobile DRAM," said IHS DRAM and memory senior principal analyst Mike Howard.
"The second quarter this year also marked a new revenue record for the segment, exceeding the peak reached in the first quarter."
While mobile DRAM was up, flash memory as a whole was down. IHS reported that sales of NAND and NOR chips are projected to hit just $24.3 billion this year, a decline of 4.7 percent from the previous year.
IHS does, however, believe that the market will bounce back. Analysts forecast that the market will pick back up next year and grow at an 11.4 percent clip on the back of continued mobile growth. By 2016, the total flash memory market could claim upwards of $33bn in annual revenues.
Scientists create a virtual reality simulation of a black hole sitting at the centre of the Milky Way
Simulations like this can help people understand complicated systems in the universe in a better way
The most luminous galaxy ever discovered is cannibalising at least three of its smaller neighbours, study finds
The galaxy radiates at 350 trillion times the luminosity of the Sun
Researchers modify genetic code of cancer-killing virus so it can target cells that protect cancer from immune system
Changing the genetic coding causes the infected cancer cells to produce a protein that kills the fibroblast cells that protect cancer
The findings can help improve the current understanding of brain development disorders, such as epilepsy or autism